Tokyo, Japan

Shihoko Maeda

This inventor holds 1 USPTO granted patent. Top assignee: Nkk Corporation. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shihoko Maeda. Retrieved from https://idiyas.com/inventor/shihoko-maeda

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shihoko Maeda: Innovator in Pharmaceutical Compositions

Introduction

Shihoko Maeda is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on arylsulfonamide derivatives. Her expertise and dedication have led to the development of valuable pharmaceutical compositions.

Latest Patents

Shihoko Maeda holds 1 patent for her invention related to arylsulfonamide derivatives and their pharmaceutical applications. This patent showcases her ability to create compounds that can potentially improve therapeutic outcomes in various medical conditions.

Career Highlights

Maeda is currently employed at NKK Corporation, where she continues to push the boundaries of pharmaceutical research. Her work at the company has been instrumental in advancing the development of new and effective medications.

Collaborations

Throughout her career, Shihoko has collaborated with notable colleagues, including Masayuki Ohmori and Shin-Ichi Sawamura. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Shihoko Maeda is a remarkable inventor whose contributions to pharmaceutical compositions have the potential to impact healthcare significantly. Her dedication to innovation and collaboration continues to inspire those in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…